Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer’s Disease in a Preclinical Model: A Therapeutic Opportunity.

por | Ene 1, 2020 | Publicaciones - C-01 | 0 Comentarios

Medina-Vera, D; Rosell-Valle, C; Lopez-Gambero, AJ; Navarro, JA; Zambrana-Infantes, EN; Rivera, P; Santin, LJ; Suarez, J; de Fonseca, FR – 2020